Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation

Tae YOO; Kwang-Woong LEE; Nam-Joon YI; Young-Rok CHOI; Hyeyoung KIM; Suk-Won SUH; Jae-Hong JEONG; Jeong-Moo LEE; Kyung-Suk SUH.
Journal of Korean Medical Science ; : 1049-1054, 2016.
Artículo en Inglés | WPRIM | ID: wpr-13359

Documentos relacionados

  1. Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
  2. The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels.
  3. Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative Treatment.
  4. Evaluating the diagnostic accuracy of heat shock proteins and their combination with Alpha-Fetoprotein in the detection of hepatocellular carcinoma: a meta-analysis.
  5. Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients.
  6. Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
  7. A study of serological markers and lipid profile in non-alcoholic liver cirrhosis patients.
  8. Sorafenib and hepatocellular carcinoma: is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?
  9. [Diagnostic value of serum alpha-fetoprotein, alpha-fetoprotein variant and abnormal prothrombin in primary hepatocellular carcinoma].
  10. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.